Related Experiment Video
Updated: Aug 9, 2026

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
Published on: October 11, 2019
Treatment of acute vivax malaria with tafenoquine
Peter Nasveld1, Scott Kitchener
1Clinical Field Section, Australian Army Malaria Institute, Gallipoli Barracks, Enoggera, Queensland 4051, Australia. peter.nasveld@defence.gov.au
Abstract:
Tafenoquine is an 8-aminoquiniline related to primaquine with pre-clinical activity against a range of malaria species. We treated two acute cases of vivax malaria with tafenoquine (800 mg over three days) alone, instead of conventional chloroquine (1500 mg over three days) and primaquine (420 mg over 14 days). In addition to the convenience of this regimen, the rapid parasite clearances observed, coupled with a good clinical response and lack of recrudescence or relapse, indicate that further investigation of tafenoquine in the treatment of vivax malaria is warranted.
Related Concept Videos
Pharmaceutical Poisoning: Treatment Strategies
Rocky Mountain Spotted Fever
Malaria
American Trypanosomiasis
Giardiasis
Antiprotozoal Agents

